{"id":"placebo-of-reference-product","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebos are inert formulations used in controlled clinical trials to serve as a comparator arm against an active drug. This particular placebo is manufactured by FLUIDDA nv to mimic the reference product's appearance, taste, texture, and administration method, enabling double-blind study design while the actual therapeutic mechanism is attributable to the reference product being tested, not the placebo itself.","oneSentence":"A placebo formulation designed to match the physical and sensory characteristics of a reference product for blinded clinical trial comparison.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:28:20.212Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT03620266","phase":"NA","title":"Effects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ole Frobert, MD, PhD","startDate":"2021-09-30","conditions":"Myocardial Infarction","enrollment":900},{"nctId":"NCT06878404","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2025-02-21","conditions":"Arthritis, Psoriatic","enrollment":552},{"nctId":"NCT07469228","phase":"PHASE1","title":"A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2025-08-04","conditions":"Acne Vulgaris","enrollment":1043},{"nctId":"NCT06654089","phase":"PHASE4","title":"A Study Evaluating Quality of Life Parameters Following Use of Emergen-C","status":"COMPLETED","sponsor":"HALEON","startDate":"2024-10-30","conditions":"Dietary Supplements","enrollment":299},{"nctId":"NCT07049055","phase":"PHASE1, PHASE2","title":"A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer","status":"RECRUITING","sponsor":"Engeneic Pty Limited","startDate":"2026-01-12","conditions":"Pancreatic Cancer, Metastatic, PDAC - Pancreatic Ductal Adenocarcinoma","enrollment":144},{"nctId":"NCT07286487","phase":"NA","title":"Glycyrrhetinic Acid and Acute Irritant Dermatitis","status":"NOT_YET_RECRUITING","sponsor":"University of Split, School of Medicine","startDate":"2026-03-01","conditions":"Irritant Contact Dermatitis","enrollment":30},{"nctId":"NCT07393802","phase":"PHASE3","title":"Evaluation of the Anti-Plaque Effect of a Resveratrol-Based Mouthwash Using a 24-Hour Plaque Re-Growth","status":"NOT_YET_RECRUITING","sponsor":"University of Baghdad","startDate":"2026-03","conditions":"Mouthwash, Chlorhexidine, Biofilm Formation","enrollment":20},{"nctId":"NCT07215767","phase":"PHASE3","title":"Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice","status":"RECRUITING","sponsor":"HALEON","startDate":"2025-09-16","conditions":"Dentin Hypersensitivity","enrollment":850},{"nctId":"NCT07357883","phase":"NA","title":"Effect of Topical Argan Oil on Healing After Laser Depigmentation.","status":"COMPLETED","sponsor":"Ghada Adayil","startDate":"2025-10-29","conditions":"Gingival Hyperpigmentation, Laser Depigmentation, Topical Argan Oil","enrollment":40},{"nctId":"NCT07295418","phase":"PHASE3","title":"A Study of SAL003 in Participants With Hypercholesterolemia and Mixed Dyslipidemia","status":"COMPLETED","sponsor":"Shenzhen Salubris Pharmaceuticals Co., Ltd.","startDate":"2023-10-23","conditions":"Hyperlipidemias","enrollment":618},{"nctId":"NCT05077332","phase":"PHASE2","title":"LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)","status":"COMPLETED","sponsor":"Leidos Life Sciences","startDate":"2021-12-29","conditions":"2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease","enrollment":4},{"nctId":"NCT06294600","phase":"PHASE3","title":"Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)","status":"RECRUITING","sponsor":"Hellenic Institute for the Study of Sepsis","startDate":"2024-02-12","conditions":"Community-acquired Pneumonia","enrollment":330},{"nctId":"NCT04925882","phase":"NA","title":"Erector Spinae Plane Block in Lumbar Release Surgery","status":"COMPLETED","sponsor":"Clinique Saint Jean, France","startDate":"2022-01-03","conditions":"Hernia Lumbar, Lumbar Canal Stenosis, Spinal Cord Compression","enrollment":100},{"nctId":"NCT04904575","phase":"NA","title":"Erector Spinae Plane Block in Lumbar Spinal Fusion","status":"RECRUITING","sponsor":"Clinique Saint Jean, France","startDate":"2022-01-03","conditions":"Lumbar Spinal Fusion","enrollment":130},{"nctId":"NCT07142356","phase":"PHASE2","title":"A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension","status":"RECRUITING","sponsor":"Retension Pharmaceuticals. Inc.","startDate":"2025-10-31","conditions":"Uncontrolled Hypertension","enrollment":280},{"nctId":"NCT07163182","phase":"PHASE1","title":"Evaluation of Safety, Side Effects and How the Drug CHF6467 Administered Via Intranasal Route is Absorbed, Modified and Removed in Healthy Subjects","status":"RECRUITING","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2025-09-15","conditions":"Healthy Volunteers","enrollment":68},{"nctId":"NCT07071363","phase":"NA","title":"COMPARISON OF A COSMETIC SERUM AND 4% HYDROQUINONE FOR TREATING MELASMA OVER 84 DAYS","status":"RECRUITING","sponsor":"Laboratoire Dermatologique ACM","startDate":"2025-06-23","conditions":"Healthy, Melasma (Facial Melasma), Epidermal Melasma","enrollment":40},{"nctId":"NCT02659865","phase":"PHASE1","title":"A Study of LY3039478 in Healthy Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2016-01","conditions":"Healthy","enrollment":29},{"nctId":"NCT06154304","phase":"PHASE3","title":"BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma","status":"COMPLETED","sponsor":"Cipla Ltd.","startDate":"2023-12-06","conditions":"Bronchial Asthma","enrollment":120},{"nctId":"NCT03971500","phase":"NA","title":"1-month vs 12-month DAPT for ACS Patients Who Underwent PCI Stratified by IVUS: IVUS-ACS and ULTIMATE-DAPT Trials","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2019-08-20","conditions":"Coronary Artery Disease","enrollment":3710},{"nctId":"NCT04661839","phase":"PHASE1","title":"A COVID-19 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered in Healthy Adults","status":"COMPLETED","sponsor":"Emergent BioSolutions","startDate":"2020-12-24","conditions":"COVID-19","enrollment":28},{"nctId":"NCT06954766","phase":"PHASE2","title":"Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981","status":"RECRUITING","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2025-05-12","conditions":"Knee Osteoarthritis","enrollment":100},{"nctId":"NCT03428711","phase":"PHASE2","title":"Mesoglycan (Prisma®) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis","status":"COMPLETED","sponsor":"Quovadis Associazione","startDate":"2018-03-26","conditions":"Superficial Venous Thrombosis of Leg, Secondary Prevention","enrollment":560},{"nctId":"NCT03212677","phase":"NA","title":"Safe and Effective Delivery of Supplemental Iron to Healthy Volunteers","status":"COMPLETED","sponsor":"Tufts University","startDate":"2017-05-17","conditions":"Iron","enrollment":226},{"nctId":"NCT06533280","phase":"PHASE1","title":"VH3739937 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers Including Relative Bioavailability (RBA), Optional Food Effect (FE), and Drug-drug Interaction (DDI)","status":"WITHDRAWN","sponsor":"ViiV Healthcare","startDate":"2024-08-02","conditions":"HIV Infections","enrollment":""},{"nctId":"NCT06146101","phase":"PHASE2, PHASE3","title":"RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA","status":"ACTIVE_NOT_RECRUITING","sponsor":"Incannex Healthcare Ltd","startDate":"2024-05-02","conditions":"Obstructive Sleep Apnea","enrollment":560},{"nctId":"NCT04056897","phase":"PHASE2","title":"Comparative Study of the Efficacy and Safety of BCD-132 With Teriflunomide and Placebo in Multiple Sclerosis","status":"COMPLETED","sponsor":"Biocad","startDate":"2019-06-07","conditions":"Multiple Sclerosis","enrollment":271},{"nctId":"NCT05656092","phase":"PHASE3","title":"A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2023-03-06","conditions":"Gastric Ulcer","enrollment":199},{"nctId":"NCT06733402","phase":"PHASE1","title":"A Study Comparing Trifarotene Cream 0.005% to AKLIEF® CREAM (US REFERENCE LISTED DRUG), AKLIEF™ CREAM (CANADIAN REFERENCE PRODUCT) in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2024-06-20","conditions":"Acne Vulgaris","enrollment":1000},{"nctId":"NCT00853866","phase":"PHASE4","title":"Enhancement of Motor Function with Reboxetine and Transcranial Direct Current Stimulation","status":"COMPLETED","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2009-01","conditions":"Cerebral Stroke","enrollment":12},{"nctId":"NCT05385744","phase":"PHASE3","title":"An International, Multicenter, Randomized, Double-Blind, Double-Masked Study of the Efficacy and Safety of BCD-132 (JSC BIOCAD, Russia) Using an Active Reference Drug (Teriflunomide) for the Treatment of Patients With Multiple Sclerosis","status":"COMPLETED","sponsor":"Biocad","startDate":"2021-04-05","conditions":"Multiple Sclerosis","enrollment":336},{"nctId":"NCT06673654","phase":"PHASE1","title":"A Study, Comparing Ruxolitinib Topical Cream 1.5% (Taro Pharmaceuticals U.S.A, Inc.) to OPZELURA (Ruxolitinib) Cream for the Treatment of Mild-to-Moderate Atopic Dermatitis.","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2023-08-11","conditions":"Atopic Dermatitis","enrollment":476},{"nctId":"NCT06673641","phase":"PHASE1","title":"A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris.","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2024-05-13","conditions":"Acne Vulgaris","enrollment":382},{"nctId":"NCT05898984","phase":"PHASE1","title":"Clinical Study to Evaluate the Safety, Tolerability and the Concentration of the BDP (Beclomethasone Dipropionate), Active Metabolite of BDP, FF( Formoterol Fumarate) and GB (Glycopyrronium Bromide), After Inhalation of CHF 5993 at Two Different Doses and QVAR®","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2023-04-24","conditions":"Asthma","enrollment":69},{"nctId":"NCT04877366","phase":"NA","title":"Evaluate Effects of Sprinkled Format REDUCOSE in a Carbohydrate-rich, Mixed Meal on Post-prandial Glycemia","status":"COMPLETED","sponsor":"Société des Produits Nestlé (SPN)","startDate":"2021-07-21","conditions":"Dietary Supplement","enrollment":30},{"nctId":"NCT06618105","phase":"PHASE3","title":"Bronchoprovocation Study to Demonstrate the Pharmacodynamic Bioequivalence of Albuterol Sulfate HFA Inhalation Aerosol (E.Q. 90 mcg of Albuterol Base/Inh) of Macleods Pharmaceuticals Ltd","status":"NOT_YET_RECRUITING","sponsor":"Macleods Pharmaceuticals Ltd","startDate":"2024-10-15","conditions":"Mild Asthma","enrollment":144},{"nctId":"NCT06154707","phase":"PHASE3","title":"Clinical Controlled Study on the Efficacy of Denosumab in Treating Osteoporosis in the Domestic Population and Its Impact on Sarcopenia-related Outcomes","status":"UNKNOWN","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2024-02-01","conditions":"Sarcopenia, Osteoporosis, Denosumab","enrollment":86},{"nctId":"NCT05763082","phase":"PHASE3","title":"Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2023-02-07","conditions":"Plaque Psoriasis","enrollment":414},{"nctId":"NCT05077969","phase":"PHASE2","title":"Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients","status":"TERMINATED","sponsor":"Leidos Life Sciences","startDate":"2021-12-29","conditions":"2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease","enrollment":4},{"nctId":"NCT01146418","phase":"PHASE3","title":"Frozen-thawed Embryo Transfer (FTET) Cycle Follow-up Protocol (P06031)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-06-02","conditions":"Infertility","enrollment":307},{"nctId":"NCT03332303","phase":"PHASE3","title":"Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy","status":"COMPLETED","sponsor":"Prasco LLC","startDate":"2017-10-26","conditions":"Vulvar and Vaginal Atrophy","enrollment":540},{"nctId":"NCT04634136","phase":"NA","title":"Full-spectrum Medical Cannabis for Treatment of Spasticity in Patients With Severe Forms of Cerebral Palsy","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2020-10-15","conditions":"Children, Adult, Spastic Cerebral Palsy, Quality of Life","enrollment":55},{"nctId":"NCT03339258","phase":"PHASE2","title":"A Randomized Controlled Trial of Doxazosin for Nightmares, Sleep Disturbance, and Non-Nightmare Clinical Symptoms in PTSD","status":"ACTIVE_NOT_RECRUITING","sponsor":"San Francisco Veterans Affairs Medical Center","startDate":"2018-04-15","conditions":"Stress Disorders, Post-Traumatic","enrollment":80},{"nctId":"NCT06045624","phase":"PHASE1","title":"A First in Human Single and Multiple Ascending Dose and Open Label Food Effect Study of OR-101 in Healthy Subjects","status":"WITHDRAWN","sponsor":"Ornovi, Inc.","startDate":"2023-10-17","conditions":"Alopecia Areata","enrollment":""},{"nctId":"NCT04619251","phase":"PHASE1","title":"A Study in Healthy Japanese Men to Test How Different Doses of BI 1323495 Are Tolerated and How Itraconazole Influences the Amount of BI 1323495 in the Blood","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2020-11-13","conditions":"Healthy","enrollment":74},{"nctId":"NCT06305637","phase":"PHASE1","title":"A Study Comparing Ketoconazole Shampoo, 2% and Ketoconazole 2% Shampoo (RS) in the Treatment of Tinea Versicolor.","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2023-12-04","conditions":"Tinea Versicolor","enrollment":430},{"nctId":"NCT04317612","phase":"NA","title":"Effect of Nordic Berries on Cognitive Function, Cardiometabolic Risk Markers and Gut Microbiota in Adults With Mild Cognitive Impairment","status":"COMPLETED","sponsor":"Region Skane","startDate":"2020-06-03","conditions":"Cognitive Impairment, Mild, Memory Impairment","enrollment":96},{"nctId":"NCT06272916","phase":"","title":"Comparison of the Effect of Aminophylline, Magnesium Sulphate and Placebo in Prevention of Post Dural Puncture Headache in Parturient Undergoing Caesarean Section.","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2024-03","conditions":"Post-Dural Puncture Headache","enrollment":630},{"nctId":"NCT05986591","phase":"PHASE3","title":"Bioequivalence Study of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Xiromed LLC","startDate":"2022-08-17","conditions":"COPD","enrollment":335},{"nctId":"NCT06192420","phase":"PHASE3","title":"TRAUMED - a Clinical Trial in Acute Ankle Sprain","status":"COMPLETED","sponsor":"Biologische Heilmittel Heel GmbH","startDate":"2018-02-26","conditions":"Ankle Sprain","enrollment":809},{"nctId":"NCT05380934","phase":"PHASE1","title":"A Clinical Trial of Safety and Tolerance of TQH3821 Tablets in Adult Healthy Subjects","status":"COMPLETED","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2022-05-29","conditions":"Rheumatoid Arthritis","enrollment":63},{"nctId":"NCT02913274","phase":"NA","title":"Arteriovenous Fistulae: Drug-eluting Balloon Angioplasty","status":"TERMINATED","sponsor":"Rennes University Hospital","startDate":"2017-03-20","conditions":"Stenosis of Arteriovenous Dialysis Fistula","enrollment":115},{"nctId":"NCT04724044","phase":"PHASE3","title":"Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia","status":"COMPLETED","sponsor":"Hellenic Institute for the Study of Sepsis","startDate":"2021-01-25","conditions":"Community-acquired Pneumonia, Sepsis, Inflammatory Response","enrollment":278},{"nctId":"NCT04890873","phase":"PHASE1","title":"ERX1000 - Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Male and Female Subjects With Obesity","status":"COMPLETED","sponsor":"ERX Pharmaceuticals","startDate":"2019-10-17","conditions":"Obesity","enrollment":48},{"nctId":"NCT05085574","phase":"PHASE2","title":"Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)","status":"WITHDRAWN","sponsor":"Leidos Life Sciences","startDate":"2023-02-07","conditions":"2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease","enrollment":""},{"nctId":"NCT04976088","phase":"PHASE3","title":"Clinical Trial With Diclofenac Sodium Medicated Plaster in Patients With Impact Injuries of the Limbs","status":"COMPLETED","sponsor":"Fidia Farmaceutici s.p.a.","startDate":"2018-05-25","conditions":"Trauma Injury, Inflammation","enrollment":214},{"nctId":"NCT06063473","phase":"PHASE1","title":"A Study Comparing Trifarotene Cream 0.005% to AKLIEF® Cream in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2023-02-22","conditions":"Acne Vulgaris","enrollment":762},{"nctId":"NCT05322707","phase":"PHASE3","title":"BE Study Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Asthma Patient","status":"COMPLETED","sponsor":"Cipla Ltd.","startDate":"2022-04-15","conditions":"Asthma","enrollment":1485},{"nctId":"NCT01329965","phase":"PHASE1","title":"Safety and Feasibility of an Endotoxemia Model","status":"COMPLETED","sponsor":"Penn State University","startDate":"2011-04","conditions":"Cardiovascular Disease, Inflammation","enrollment":6},{"nctId":"NCT03004404","phase":"PHASE1","title":"To Assess Safety, Tolerability and Pharmacokinetics of BI 730357 in Healthy Male Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2017-01-12","conditions":"Healthy Volunteers","enrollment":84},{"nctId":"NCT05993143","phase":"PHASE3","title":"Ivermectin to Prevent SARS-CoV-2 (COVID-19) Hospitalisation in Subjects Over 50","status":"TERMINATED","sponsor":"Insud Pharma","startDate":"2021-01-18","conditions":"COVID-19, SARS-CoV-2","enrollment":249},{"nctId":"NCT01966120","phase":"PHASE3","title":"Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)","status":"COMPLETED","sponsor":"Biofrontera Bioscience GmbH","startDate":"2013-10","conditions":"Actinic Keratosis","enrollment":87},{"nctId":"NCT01044264","phase":"NA","title":"Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2007-12","conditions":"Acne Vulgaris","enrollment":602},{"nctId":"NCT01039584","phase":"NA","title":"A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% Formulations","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2008-02","conditions":"Vulvovaginal Candidiasis","enrollment":611},{"nctId":"NCT05693441","phase":"NA","title":"Study on the Chronic and Acute Effects of Nordic Berry Beverage on Cognitive Function","status":"COMPLETED","sponsor":"Aventure AB","startDate":"2023-01-17","conditions":"Age-related Cognitive Decline","enrollment":62},{"nctId":"NCT05484401","phase":"PHASE3","title":"Ibuprofen Liquid Capsules 2 x 200 mg Efficacy and PK/PD Study in Surgical Removal of Impacted Third Molars","status":"COMPLETED","sponsor":"Reckitt Benckiser Healthcare (UK) Limited","startDate":"2022-08-09","conditions":"Tooth, Impacted, Tooth Diseases, Stomatognathic Diseases","enrollment":294},{"nctId":"NCT05844085","phase":"NA","title":"Effects of Plant-based Polar Lipids on Acute and Second Meal Glucose Tolerance and Appetite Sensations","status":"COMPLETED","sponsor":"Lund University","startDate":"2023-05-05","conditions":"Healthy Subjects, Diet Intervention","enrollment":20},{"nctId":"NCT02246920","phase":"PHASE3","title":"Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis Patients","status":"TERMINATED","sponsor":"Teva Pharmaceuticals USA","startDate":"2014-03-01","conditions":"Seasonal Allergic Rhinitis","enrollment":1474},{"nctId":"NCT05161156","phase":"PHASE3","title":"Bioequivalence Study of Tiotropium Bromide Inhalation Powder","status":"COMPLETED","sponsor":"Phargentis SA","startDate":"2022-03-24","conditions":"COPD","enrollment":306},{"nctId":"NCT05078827","phase":"PHASE3","title":"Therapeutic Equivalence of Fluorouracil Cream, 5% Compared With Fluorouracil 5% Topical Cream of MylanPharmaceuticals Inc., U.S.A in the Treatment of Actinic Keratosis","status":"COMPLETED","sponsor":"Encube Ethicals Pvt. Ltd.","startDate":"2022-03-01","conditions":"Actinic Keratoses","enrollment":458},{"nctId":"NCT05664061","phase":"PHASE3","title":"Bioequivalence With Clinical Endpoint Study of Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma","status":"UNKNOWN","sponsor":"Respirent Pharmaceuticals Co Ltd.","startDate":"2023-01-30","conditions":"Asthma","enrollment":451},{"nctId":"NCT03611101","phase":"","title":"Companion Protocol for ¹³C-Methacetin Breath Tests in BMS: NCT03486899, NCT03486912 Referenced Trials","status":"COMPLETED","sponsor":"Meridian Bioscience, Inc.","startDate":"2018-05-04","conditions":"NASH - Nonalcoholic Steatohepatitis","enrollment":124},{"nctId":"NCT03238534","phase":"PHASE4","title":"Efficacy and Safety Evaluation of Neobianacid® in GERD and EPS","status":"COMPLETED","sponsor":"Aboca Spa Societa' Agricola","startDate":"2017-09-12","conditions":"GERD, EPS","enrollment":275},{"nctId":"NCT05200741","phase":"PHASE2","title":"To Evaluate Safety & Immunogenicity of DelNS1-2019-nCoV-RBD-OPT1 for COVID-19 in Healthy Adults Received 2 Doses of BNT162b2","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2022-02-08","conditions":"Covid19","enrollment":150},{"nctId":"NCT03015259","phase":"PHASE3","title":"Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients","status":"COMPLETED","sponsor":"Kindeva Drug Delivery","startDate":"2016-12-29","conditions":"Asthma","enrollment":1762},{"nctId":"NCT04690335","phase":"PHASE2","title":"Human Challenge Study to Evaluate the Efficacy of MV-012-968 Vaccine","status":"COMPLETED","sponsor":"Meissa Vaccines, Inc.","startDate":"2020-12-29","conditions":"RSV Infection","enrollment":60},{"nctId":"NCT05024721","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2021-08-09","conditions":"Gastritis","enrollment":326},{"nctId":"NCT02611830","phase":"PHASE3","title":"Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis","status":"COMPLETED","sponsor":"Takeda","startDate":"2015-12-18","conditions":"Colitis, Ulcerative","enrollment":383},{"nctId":"NCT04873063","phase":"PHASE1","title":"Evaluation of Systemic Bioavailability and Effects on 24-Hour Plasma Cortisol Profile of 6 mg Delivered Once Daily Versus 3 mg Delivered Twice Daily in Healthy Adult Male Volunteers","status":"COMPLETED","sponsor":"SOFAR S.p.A.","startDate":"2021-10-22","conditions":"Healthy Adult Male Volunteers","enrollment":28},{"nctId":"NCT05282771","phase":"EARLY_PHASE1","title":"A Study Comparing Halobetasol Propionate and Tazarotene Topical Lotion 0.01%/0.045% to Duobrii® Lotion (Halobetasol Propionate and Tazarotene Lotion), 0.01%/0.045% (Reference Listed Drug) in the Treatment of Moderate to Severe Plaque Psoriasis.","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2021-04-16","conditions":"Plaque Psoriasis","enrollment":402},{"nctId":"NCT05270954","phase":"PHASE1, PHASE2","title":"Safety, Tolerability and Immunogenicity of Recombinant COVID-19 Vaccine Betuvax-CoV-2","status":"UNKNOWN","sponsor":"Artgen Biotech","startDate":"2021-10-14","conditions":"COVID-19","enrollment":116},{"nctId":"NCT00702624","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05690 (Care Program) (P05710)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-04","conditions":"Pregnancy, Neonates","enrollment":113},{"nctId":"NCT00702546","phase":"","title":"Follow-up Protocol on the Outcome of Frozen-thawed Embryo Transfer Cycles From Clinical Trial P05690 (P05711)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-12","conditions":"In Vitro Fertilization","enrollment":102},{"nctId":"NCT05102643","phase":"PHASE1","title":"A Study to Evaluate Safety & Immunogenicity of SARS-CoV-2 DNA Vaccine Delivered Intramuscularly Followed by Electroporation for COVID-19","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2021-11-18","conditions":"Covid19","enrollment":30},{"nctId":"NCT02227394","phase":"PHASE2","title":"Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients","status":"COMPLETED","sponsor":"Zambon SpA","startDate":"2014-08","conditions":"Asthma, Asthma Chronic, Asthma Bronchial","enrollment":20},{"nctId":"NCT03700658","phase":"PHASE1","title":"A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous (SC) Administration of TV-46046","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2019-01-15","conditions":"Contraception","enrollment":27},{"nctId":"NCT04682873","phase":"PHASE3","title":"A Clinical Study to Assess the Efficacy and Safety of Amizon® Max in the Treatment of Moderate Covid-19, Caused by the SARS-CoV-2 Virus","status":"COMPLETED","sponsor":"Joint Stock Company \"Farmak\"","startDate":"2020-05-15","conditions":"Covid-19 Disease","enrollment":592},{"nctId":"NCT05148689","phase":"PHASE1","title":"A Study Comparing Oxymetazoline 1% Cream to RHOFADE","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2018-02-23","conditions":"Bioequivalence","enrollment":82},{"nctId":"NCT02515305","phase":"PHASE3","title":"Comparative Safety and Efficacy of Two Treatments in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2015-07","conditions":"Acne","enrollment":890},{"nctId":"NCT03393494","phase":"PHASE3","title":"Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2017-12-13","conditions":"Acne Vulgaris","enrollment":825},{"nctId":"NCT02459795","phase":"PHASE3","title":"To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2015-05","conditions":"Actinic Keratosis","enrollment":469},{"nctId":"NCT02525549","phase":"PHASE3","title":"Comparative Safety and Bioequivalence of Two Treatments in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2011-12","conditions":"Acne","enrollment":903},{"nctId":"NCT02795117","phase":"PHASE3","title":"Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2016-05","conditions":"Rosacea","enrollment":486},{"nctId":"NCT02770365","phase":"PHASE3","title":"Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal Atrophy","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2016-05","conditions":"Atrophy","enrollment":695},{"nctId":"NCT02385318","phase":"PHASE3","title":"To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2015-02","conditions":"Actinic Keratosis","enrollment":519},{"nctId":"NCT00804193","phase":"NA","title":"Safety and Equivalence of a Generic Ciclopirox Olamine Topical Suspension Compared to the Reference Ciclopirox Topical Suspension 0.77% for the Treatment of Tinea Pedis","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2004-06","conditions":"Tinea Pedis","enrollment":553},{"nctId":"NCT01673659","phase":"PHASE3","title":"A Safety and Bioequivalence of a Mometasone Nasal Spray, 50 mcg/Actuation Compared With Nasonex® Nasal Spray 50 mcg/Actuation in the Relief of the Symptoms of Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2012-08","conditions":"Seasonal Allergic Rhinitis","enrollment":1220},{"nctId":"NCT02385240","phase":"PHASE3","title":"Comparative Safety and Efficacy of Two Rosacea Products in the Treatment of Facial Erythema of Rosacea","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2015-03","conditions":"Rosacea","enrollment":552},{"nctId":"NCT02265913","phase":"PHASE3","title":"Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2014-10-06","conditions":"Herpes Labialis","enrollment":4076},{"nctId":"NCT02230696","phase":"PHASE3","title":"Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2014-08","conditions":"Seasonal Allergic Rhinitis","enrollment":951}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":25,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo inhaler containing HFA propellant resembling the reference active inhaler"],"phase":"phase_3","status":"active","brandName":"Placebo of Reference product","genericName":"Placebo of Reference product","companyName":"FLUIDDA nv","companyId":"fluidda-nv","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}